Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
The Lancet. Infectious Diseases
Hardt, Karin K; Vandebosch, An A; Sadoff, Jerald J; Le Gars, Mathieu M; Truyers, Carla C; Lowson, David D; Van Dromme, Ilse I; Vingerhoets, Johan J; Kamphuis, Tobias T; Scheper, Gert G; Ruiz-Guiñazú, Javier J; Faust, Saul N SN; Spinner, Christoph D CD; Schuitemaker, Hanneke H; Van Hoof, Johan J; Douoguih, Macaya M; Struyf, Frank F; ,